Hennion & Walsh Asset Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.21M | Sell |
49,900
-9,373
| -16% | -$978K | 0.21% | 105 |
|
|
2025
Q1 | $6.91M | Buy |
59,273
+1,437
| +2% | +$168K | 0.31% | 58 |
|
|
2024
Q4 | $4.89M | Sell |
57,836
-312
| -0.5% | -$26.4K | 0.22% | 98 |
|
|
2024
Q3 | $5.23M | Sell |
58,148
-6,537
| -10% | -$587K | 0.24% | 93 |
|
|
2024
Q2 | $5.21M | Sell |
64,685
-4,798
| -7% | -$386K | 0.27% | 78 |
|
|
2024
Q1 | $5.54M | Buy |
69,483
+8,867
| +15% | +$708K | 0.3% | 64 |
|
|
2023
Q4 | $4.82M | Sell |
60,616
-6,430
| -10% | -$512K | 0.28% | 75 |
|
|
2023
Q3 | $4.69M | Sell |
67,046
-10,391
| -13% | -$726K | 0.3% | 71 |
|
|
2023
Q2 | $5.57M | Sell |
77,437
-16,827
| -18% | -$1.21M | 0.33% | 65 |
|
|
2023
Q1 | $5.81M | Buy |
94,264
+1,074
| +1% | +$66.2K | 0.36% | 64 |
|
|
2022
Q4 | $7.19M | Sell |
93,190
-13,392
| -13% | -$1.03M | 0.44% | 48 |
|
|
2022
Q3 | $4.76M | Buy |
106,582
+8,092
| +8% | +$361K | 0.31% | 72 |
|
|
2022
Q2 | $3.77M | Sell |
98,490
-6,647
| -6% | -$255K | 0.23% | 115 |
|
|
2022
Q1 | $4.35M | Buy |
105,137
+10,090
| +11% | +$418K | 0.23% | 116 |
|
|
2021
Q4 | $3.59M | Buy |
95,047
+14,836
| +18% | +$561K | 0.18% | 162 |
|
|
2021
Q3 | $2.64M | Buy |
80,211
+3,984
| +5% | +$131K | 0.14% | 208 |
|
|
2021
Q2 | $5.14M | Buy |
76,227
+18,054
| +31% | +$1.22M | 0.27% | 86 |
|
|
2021
Q1 | $3.29M | Buy |
+58,173
| New | +$3.29M | 0.2% | 139 |
|